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Fructose rich diet (FRD) has been associated with obesity development, which is 
characterized by adipocytes hypertrophy and chronic low-grade inflammation. Interaction of 
adipocytes and immune cells play a key role in adipose tissue (AT) alterations in obesity. We 
assessed the metabolic and immune impairments in AT in a murine obesity model induced 
by FRD at different periods. Adult Swiss mice were divided into groups of 6 and 10 weeks of 
fructose (FRD 6wk, FRD 10wk) or water intake (CTR 6wk, CTR 10wk). FRD induced increased 
in body weight, epidydimal AT mass, plasmatic and liver Tg, and impaired insulin sensitivity. 
Also, hypertrophic adipocytes from FRD 6wk-10wk mice showed higher IL-6 when stimulated 
with LPS and leptin secretion. Several of these alterations worsened in FRD 10wk. Regarding 
AT inflammation, FRD mice have increased TNFα, IL-6, IL1β, and decrease in IL-10, CD206 
mRNA levels. Using CD11b, LY6C, CD11c and CD206 as macrophages markers, we identified 
for first time in AT M1 (M1a: Ly6C+/-CD11c+CD206- and M1b: Ly6C+/-CD11c+CD206+) and 
M2 subtypes (Ly6C+/-CD11c-CD206+). M1a phenotype increased from 6 weeks onward, 
while Ly6C+/- M1b phenotype increased only after 10 weeks. Finally, co-culture of 
RAW264.7 (monocytes cell line) and CTR or FRD adipocytes showed that FRD 10wk 
adipocytes increased IL-6 expression in non- or LPS-stimulated monocytes. Our results 
showed that AT dysfunction got worse as the period of fructose consumption was longer. 
Inflammatory macrophage subtypes increased depending on the period of FRD intake and 



























Worldwide incidence of obesity has reached dramatic levels, making it one of the main 
concerns for the public health system. World Health Organization (WHO) defines obesity as 
adipose tissue (AT) excess which may be harmful for health. AT excess is generated by the 
imbalance between calories intake and energy expenditure, where energy excess is stored 
mainly in AT, favoring its expansion. Obesity and overweight, especially abdominal fat 
accumulation,  are major risk factors for a number of noncommunicable diseases including 
cardiovascular disorders, dyslipidemia, insulin resistance and certain cancers, among others 
[1–5]. 
Several factors, such as sedentary lifestyle and unbalanced diets, have converged to create the 
actual obesogenic environment. Regarding diets, high content of fat and sugar has been 
associated to detrimental effects on health. Thus, high fructose content in sweetened 
beverages has been associated to high prevalence of overweight and Metabolic Syndrome 
(MS)[6,7]. Besides, calories provided by sugar-sweetened beverages have little nutritional 
value and may not provide the same feeling of satiety as solid food. As an overall result, total 
energy intake increases, leading to unhealthy weight gain and co-morbidities (WHO). In animal 
models, fructose rich diet (FRD) has been related to the development of insulin resistance, 
dyslipidemias, increased abdominal AT mass, and changes in the pattern of AT adipokine 
secretion [8,9]. To some extent, these metabolic disorders are the consequence of fructose-
induced hepatic de novo lipogenesis and the resulting increase in AT fatty acid uptake [10–12]. 
AT expansion implies tissue remodeling, which includes among others, the increase in number 
and size of adipocytes, and the recruitment and activation of immune cells. Hypertrophic 
adipocytes secrete more leptin and inflammatory cytokines, lower adiponectin and become 
insulin resistant [13]. Changes in the adipokine secretion pattern contribute to develop 
metabolic disorders and chronic low-grade inflammation, hallmark of obesity [14,15]. The AT 
inflammatory status plays a key role in the establishment of insulin resistance and AT 
macrophages (ATMs) are crucial for this process. It is known that macrophages may develop 
different phenotypes which play different roles in AT homeostasis. Using simplified criteria, the 
different populations of ATMs can be classified as classical (M1, pro-inflammatory) and 
alternative (M2, anti-inflammatory) activated macrophages. M1 macrophages are 
characterized by releasing IL-6, IL-1β, TNFα, and by having enhanced iNOS activity, while M2 
















resident ATMs mainly correspond to M2 type. Conversely, when chronic caloric excess persists 
and AT mass expansion is established, classical inflammatory ATMs are recruited and 
activated, leading to an increase in their number [16], while local proliferation and 
differentiation could contribute to the pathophysiological process [17]. 
Different monocyte/macrophage phenotypes have been described and are still a matter of 
debate. Monocytes can be characterized by the differential expression of an inflammatory 
marker Ly6C, being further divided as Ly6C+(Ly6Chigh+ Ly6C middle) and Ly6C- (Ly6Clow). The first 
ones are more abundant in circulation, may be recruited into inflamed tissues and are capable 
to produce inflammatory cytokines when activated. In steady state, they may differentiate to 
Ly6C- and become resident macrophages when they reach the tissue [18,19]. It is still 
controversial whether the latter ones may be activated to pro-inflammatory macrophages or 
to an intermediate phenotype. Moreover, CD11c has been widely used as a marker for M1 
macrophages, while CD206 for M2 macrophages. A recent report has described the presence 
of CD206 marker in M1 ATMs splitting the M1 population into M1a for CD11c+ CD206- cells and 
M1b for double positive CD11c+ CD206+ cells [20]. However, their origin and role in AT are still 
unknown. 
A bi-directional interaction between adipocytes and ATMs has been widely studied and 
depending on the signals that both cellular types generate, they could modulate each other 
[21–23]. Adipocytes are capable to produce leptin, adiponectin, MCP-1, and pro-inflammatory 
cytokines, and may favor M1 or M2 ATMs, while cytokines derived from macrophages M1 and 
M2 impair or improve adipogenesis and insulin sensitivity, respectively. 
For the present study we used a mouse model of fructose-induced obesity to assess the 
metabolic and inflammatory profile during two different periods: short FRD (6 weeks; FRD 
6wk) and longer and chronic FRD (10 weeks; FRD 10wk). We mainly focused on the innate 
immune macrophage populations, M1 and subpopulations, M1a and M1b, and M2, with a 
novel set of markers CD11b, Ly6C, CD11c, and CD206. It is the first time that Ly6C marker is 
used to study ATM populations. Moreover, we studied the immune crosstalk between 
adipocytes and macrophages after the FRD. 
2. Material and Methods 
2.1. Animals and treatment 
Normal adult male Swiss mice (four months of age) were kept in a temperature-controlled 
















with commercial rodent chow (Purina, Argentina). Mice were randomly group-housed: control 
animals were provided tap water for 6 or 10 weeks (CTR 6wk and CTR 10wk, respectively) or 
20% fructose solution (wt/vol, Sigma-Aldrich, St. Louis, MO, USA) added to tap water for 6 or 
10 weeks (conventionally called fructose rich diet, FRD 6wk and FRD 10wk, respectively). Food 
intake and body weight were measured every 48 h. On experimental day, mice were 
euthanized under non-fasting conditions (08:00 to 09:00 h) and trunk blood was collected; 
plasma samples were then frozen (– 20°C) until metabolite measurements. Inguinal AT (IAT, 
subcutaneous depot), Epididymal AT (EAT, visceral depot) and Retroperitoneal AT (RPAT, 
visceral depot) were aseptically dissected and weighed. EAT was kept in sterile Dulbecco's 
Modified Eagle's Medium-Low Glucose (1 g/L) (DMEM-LG) for further procedures. Animals 
were euthanized according to protocols for animal use, in agreement with NIH guidelines for 
the care and use of experimental animals. All experiments were approved by our Institutional 
Animal Care Committee. 
2.2. Peripheral metabolite measurements 
Plasma levels of leptin (Lep) were determined by specific radioimmunoassays (RIAs) previously 
developed in our laboratory [24]. Circulating glucose (Glu), triacylglycerol (Tg), aspartate 
aminotransferase (AST), and alanine aminotransferase (ALT) levels were measured using 
commercial kits (Wiener Lab., Rosario, Argentina). 
2.3. EAT stromal vascular fraction cells and adipocytes isolation  
Fresh EAT pads were dissected, weighed and digested with collagenase as previously reported 
[25]. Briefly, fat tissue was minced and digested using 1 mg/mL collagenase solution in DMEM-
LG (at 37ºC, for 1h). After centrifugation (1,000 rpm, during 15 min), floating mature 
adipocytes on the top were separated [25,26] and washed with DMEM-LG 1% BSA (x3). Then 
adipocytes were resuspended in DMEM-LG-1% BSA for later experiments. Precipitated SVF at 
the bottom of the tube were separately collected, filtered (in a 50 µm mesh nylon cloth) and 
washed with DMEM-LG (x3). SVF cells were then resuspended in DMEM-LG supplemented 
with 10% (v/v) fetal bovine serum (FBS), HEPES (20 nM), 100 IU/mL penicillin, and 100 µg/mL 
streptomycin (basal medium) and reserved for further measurements. 
2.4. Adipocyte culture 
Adipocytes were diluted up to a density of approximately 200,000 cells in DMEM-LG-1% BSA 
and distributed in 24 multi-well plates. For leptin quantification, cells were incubated for 45 
















frozen (-20°C) until measurement as described in section 2.9. Additionally, another set of 
adipocytes was incubated overnight (ON) under basal conditions (DMEM-LG-1% BSA) or in 
presence of LPS (DMEM-LG-1% BSA supplemented with 100ng/ml LPS) for further 
measurement of IL-6 in the supernatants by ELISA (BD OptEIA IL-6). 
2.5. Histology 
For EAT histological studies, freshly dissected EAT pads were fixed in 4% paraformaldehyde, 
then washed with tap water, immersed in a series of graded ethanol (70, 96 and 100%), and 
clarified in xylene before paraffin embedding [28]. Four-micrometer sections were taken from 
different levels of the blocks and stained with hematoxylin-eosin. Quantitative morphometric 
analysis was performed using a RGB CCD Sony camera and the automated Open Source 
software Adiposoft as a plug-in for Fiji software [29](magnification, x400). For each tissue 
sample, seven sections and three levels were selected. Systematic random sampling was used 
to select 15 fields for each section, and 2,500 cells per group were examined. Adipocyte area 
was measured [30]. 
For histological liver study, fresh samples were fixed in 4% paraformaldehyde for 24 h. Then, 
they were immersed in different ethanol concentrations (96 and 100%) followed by xylene 
incubation. Finally, livers were embedded in paraffin, 5-6 µm sections were taken from 
different levels of the block and then stained with hematoxylin-eosin. Representative images 
were taken using a RGB CCD Sony camera. 
2.6. Glucose tolerance test (GTT). 
Four days before the end of the protocols, the experimental groups were fasted overnight and 
then glucose (2 mg/kg BW) was injected i.p. Blood was collected by the tail cut method. 
Glucose was measured at 0, 30, 60 and 120 min after glucose challenge using a one-touch 
glucometer (Accu-Chek Performa). Area under the curve was calculated using Graph Pad Prism 
6.0. 
2.7. Liver lipid content 
Fifty mg of liver was homogenized in 500 µL of 5% solution of Triton X-100 in PBS. The 
homogenate was incubated at 80-100°C for 5 min and centrifuged at 10,000 g for 10 min. Tg 
was measured in the supernatants using a commercial kit (Wiener Lab, Rosario, Argentina). 
















Total RNA was isolated from cells by the Trizol extraction method (Invitrogen, Life Tech., USA) 
and reverse-transcribed using random primers (250 ng) and RevertAid Reverse Transcriptase 
(200 U/ul, Thermo Scientific, Lithuania). Two μL cDNA were amplified with HOT FIRE Pol 
EvaGreenqPCR Mix Plus (Solis BioDyne, Estonia) containing 0.5 μM of each specific primer, 
using a Rotor Gene Q (Qiagen, Hilden, Germany). PCR efficiency was near 1. Expression levels 
were analyzed for β-actin (ACTβ, reporter gene), Adiponectin (Adipo), Leptin (Ob), Tumor 
Necrosis Factor α (TNFα), Interleukin 1β (IL-1β), Interleukin 6 (IL-6), Interleukin 10 (IL-10), and 
mannose receptor (CD206). Designed primers are shown in Table 1. Relative changes in the 
expression level of one specific gene were calculated by the ΔΔCt method. 
2.9. Culture medium measurement  
Medium leptin concentration was determined by specific RIA [26]. In this assay, the standard 
curve ranged between 50 and 12,500 pg/mL, with intra- and inter-assay variation coefficients 
of 4-6 and 5-8 %, respectively. IL-6 in culture medium was measured following the instructions 
of the manufacturer (BD OptEIA IL-6). The curve ranged from 16 pg/ml to 1000 pg/ml. 
2.10. Flow cytometry analysis 
SVF was prepared as reported above. Cell suspensions were then filtered through a 70-µm cell 
strainer and cells were stained after Fc blocking. Directly fluorochrome-conjugated anti-mouse 
antibodies or the respective isotype control were used for specific immunostainings (1:50-100 
dilutions). For myeloid analysis anti-CD11b (M1/70, BDPharmigen cat#550993), anti-CD11c 
(HL3, BD cat# 557401), anti-CD206 (C068C2, BioLegend) anti-Ly6C (AL-21, BD cat#553104) 
were used. Cells were analyzed in a FACS Calibur flow cytometer (BD bioscience). Analysis was 
performed using CellQuest Pro (Becton-Dickinson, San Jose, CA, USA) and FlowJo software 
(TreeStar, San Carlo, CA, USA). 
 
2.11. Adipocytes and monocyte cell line (RAW264.7) co-culture  
Direct co-cultures were performed by adding adipocytes from EAT (2x105cells) to 24-well 
plates containing RAW264.7 cells (8 x 104cells, monocytes cell line) in DMEM-LG 1% FBS ON. 
Adipocytes remained floating, forming a cell top layer in the culture well, avoiding direct 
contact with RAW cells. Then, adipocytes were removed and RAW264.7 culture was washed 
with Hank’s solution (x5). DMEM-LG medium from co-culture was stored at -80ºC for IL-6 ELISA 
analysis. Then, RAW264.7 cells were divided into three groups depending on the stimulus they 
















(100 ng/ml) or control medium supplemented with IL-4 (10 ng/ml) for 6 h. Finally, total RNA 
was extracted from RAW264.7 cells and processed for qPCR quantification of pro-
inflammatory (IL-6) or anti-inflammatory (CD206) markers.  
2.12. Statistical analysis 
Results are expressed as mean values ± SD. Metabolic parameters and flow cytometry studies 
were analyzed by ANOVA (two-way) with Tukey’s multiple comparison test. For the GTT a two-
way ANOVA with repeated measures (mixed model) was performed. In vitro studies were 
analyzed by ANOVA (one-way) with Tukey’s multiple comparison test. P values lower than 0.05 
were considered statistically significant. All statistical tests were performed using GraphPad 
Prism 6.0 (GraphPad Software Inc., San Diego, CA, USA). 
3. Results 
3.1. Metabolic effects of FRD  
In a recent work, we showed the effect 6-week FRD on several metabolic parameters in Swiss 
mice [31]. In this study we compared them with longer periods of fructose consumption (10 
weeks, 10wk) that generated a larger deleterious effect in some of them. Moreover, we 
continued this study analyzing the inflammatory profile of AT in both periods.  
Although FRD mice consumed less food than CTR mice (CTR: 3.05 ± 0.32 gr/mice/day vs. FRD: 
2.13 ± 0.31 gr/mice/day; P≤0.003), they were on a hypercaloric diet from 3 to 10 weeks of the 
experiment due to the calories provided by fructose (FRD: calories from Chow: 5.44 ± 0.52 
Kcal/mice/day plus calories from fructose: 6.31 ± 0.54 kcal/mice/day vs. CTR: 8.77 ± 
0.78kcal/mice/day). Thus, they showed a significant increase in body weight compared to CTR 
littermates from fifth week (Fig. 1A, B). Briefly, the metabolic profile of FRD mice was 
deteriorated by fructose consumption in both periods, evidenced by the increase in plasma Tg 
and Lep levels; nevertheless, no changes in basal Glu levels were observed (Fig. 1D,E,F). Of 
notice, after 10 weeks of FRD Lep levels were significantly higher than in FRD 6wk group. 
Moreover, when FRD mice were subjected to a GTT, both FRD groups showed an altered 
glucose management evidenced in the glucose curve and the AUC, indicating an impairment in 
insulin sensitivity in peripheral tissues (Fig. 1C). Even there was not a significant difference 
between the periods, after 10 weeks the AUC was higher than after 6 weeks.  
















As previously shown, FRD produced an increase in the mass of AT depots. After 6 weeks only 
EAT was significantly increased [31]. Interestingly, after 10 weeks of FRD a significant increase 
in EAT and IAT mass was evidenced (Fig. 2 A, B), showing the deleterious effect of long periods 
of fructose intake. For RPAT no differences were observed at any period studied (Fig. 2C). For 
further studies of AT, we focused on EAT as it showed the most evident increase in AT mass for 
both periods, and because it is known to be metabolically more active than subcutaneous AT 
and harbor more immune cells [32]. EAT mass expansion in FRD mice was accompanied by an 
increase in adipocyte size (Fig. 2D), indicating that the nature of EAT expansion caused by 
fructose ingestion was mainly hypertrophic. Even more, as fructose consumption periods were 
extended, hypertrophy got worse and the adipocytes area after FRD 10wk was significantly 
larger compared to that of FRD 6wk (Fig. 2E). No differences in CTR adipocytes area were 
found for all timings studied. When we analyzed adipocyte functionality by measuring Lep 
release during adipocytes culture, we found that FRD adipocytes released higher amounts of 
Lep into the culture medium than CTR adipocytes (Fig. 2F) and, as observed for plasma Lep, 
amounts were significantly higher after 10 than 6 weeks of FRD. Regarding, metabolic mRNA 
expression, ob was higher in EAT from FRD 6wk and 10wk mice and no differences were 
observed for the periods analyzed. Adipo gene expression showed no differences after 6 weeks 
of FRD compared to CTR. Contrarily, after 10 weeks of FRD a significant decrease in its 
expression was detected (Fig. 2G).  
Finally, we evaluated the liver status after the different periods of fructose intake. We 
assessed the liver metabolic enzyme levels (ALT and AST) that are surrogate markers used to 
assess liver damage. In our model, ALT levels were significantly increased only after 10 weeks 
of FRD (Fig 3A) whereas AST remained unchanged, indicating some liver impairment after a 
longer period of FRD. Then, we continued studying the triglycerides liver content and observed 
an increase in FRD-fed mice groups compared to CTR (Fig. 3B). Interestingly, FRD 10wk group 
showed almost twice-fold liver TG compared with the 6wk counterpart. Moreover, the liver 
histology showed some parenchymatous degeneration of hepatocytes for both FRD periods 
studied (ballooning) and some foci of lipid accumulation after 10 weeks (Fig. 3C). Overall, these 
results indicate that longer periods of FRD altered many metabolic parameters causing AT 
hypertrophy and affecting the liver histology and functionality.  
3.3. FRD favored pro-inflammatory profile (mRNA and M1 subtypes) and reduced anti-
















mRNA expression of inflammatory and anti-inflammatory markers was then assessed in AT. 
We observed that pro-inflammatory markers IL-6 and TNFα were significantly high for both 
periods of FRD, but IL-1β was significantly higher only after 10wk (Fig. 4A). Anti-inflammatory 
markers showed a reduction in CD206 and IL-10 being significant after 6wk in the case of 
CD206 and after 10wk in the case of IL-10 (Fig. 4B). These results indicated a reduction in the 
anti-inflammatory profile of M2 ATM in the EAT. 
Most studies and reviews have assessed macrophages activation in different tissues during 
obesity, but detailed information about the different populations during the progression of the 
disease is scarce. Thus, we studied the adipose tissue monocyte-derived macrophages 
(CD11b+, Ly6C+) by flow cytometry from the SVF of EAT after the two different periods of FRD. 
We observed a significant increase of this population only after 10 weeks (Fig. 5A,B), indicating 
a higher recruitment of monocytes from blood. When separated by Ly6Chigh (phagocytosis and 
pro-inflammatory) or Ly6Cmiddle (pro-inflammatory) we observed a significant increase in the 
percentage of the latter population for both periods studied, but the Ly6Chigh population was 
significantly larger after 10 weeks of FRD indicating a higher AT inflammatory status as the 
fructose exposure increased. 
Then, we continued studying the pro-inflammatory marker CD11c of adipose tissue 
macrophages (ATM). Figure 5 C, D shows a significant increase in Ly6C+ and Ly6C- M1 
macrophages compared to controls. Interestingly, the proportion of Ly6C-M1 macrophages 
was higher than that of Ly6C+ M1. As Ly6C- macrophages are principally considered tissue 
resident, these cells may be activated prior to the arrival of classical macrophages or 
negativized in the tissue after a certain time in it. To our surprise no differences were observed 
between the treatments tested.  
M1 macrophages can be divided into two subtypes: M1a and M1b, depending on the 
expression of CD206. Even though this marker is commonly used for M2 macrophages 
determination, M1b macrophages have been found to express this receptor [20]. When 
specifically different M1 subtypes were evaluated, interesting results were observed. We 
separated them into four different populations regarding if they expressed Ly6C+ or CD206+ or 
not. For the M1b (Ly6C+/-) ATM no differences were observed after FRD 6wk; only after 10wk 
(Fig. 5, E) treatment there was a significant increase in this population independently of Ly6C. 
For M1a (Ly6C+/-) ATM the percentage was increased compared to CTR for both periods 
studied. Of notice, M1a population was larger than that of M1b, and Ly6C- M1a ATMs were the 
















M1b population may show a different activation kinetics than M1a, which is triggered after a 
proinflammatory environmental exposure and participates in tissue remodeling [33]. 
On the other hand, we found that the M2 anti-inflammatory ATM population (CD11b+, CD206+, 
CD11c-) decreased immediately after 6wk of FRD and continued low after 10wk (Fig. 5F). When 
separated between Ly6C+/- ATMs, we did not find any change in Ly6C+ M2 ATMs population for 
both periods studied (Fig. 5D). Moreover, its proportion/percentage was noticeably low. Ly6C- 
M2 ATMs was the most numerous population but significantly decreased after FRD (6 and 
10wk) representing the resident ATMs population.  
3.4. Macrophage activation by adipocytes in vitro 
In order to assess the capacity of adipocytes to produce IL-6 after FRD, mature adipocytes 
were cultured ON with and without LPS stimulation. IL-6 release was measured by ELISA in the 
culture medium (Fig. 6A). After 6 weeks of FRD we observed that FRD and CTR LPS adipocytes 
released slightly higher amounts of IL-6 compared to CTR adipocytes, though values were not 
significant. Notably, adipocytes from FRD 6wk group significantly increased IL-6 release after 
stimulation with LPS compared to the other groups. On the other hand, after 10 weeks of FRD 
we observed that FRD adipocytes under basal conditions already produced significantly higher 
amounts of IL-6 compared to CTR adipocytes. When adipocytes were stimulated with LPS a 
higher release of IL-6 was observed for both groups but FRD LPS adipocytes produced the 
highest amount, significantly different compared to all the other groups. Of notice, FRD 10wk 
adipocytes under basal conditions or after LPS stimulation from 10wk group produced higher 
IL-6 than their counterparts from 6wk groups. Thus, FRD adipocytes increase their IL-6 release 
as time of fructose consumption extends, probably favoring the worsening of the disease and 
contributing to the AT hypertrophy.  
Finally, with the aim of assessing whether adipocytes were capable of imprinting monocytes 
prior to stimulation with LPS (induction to M1) or IL-4 (M2) we co-cultured adipocytes and 
RAW264.7 monocytes ON and then monocytes were stimulated or not with LPS or IL4.  
First, when co-culture was analyzed without any extra stimulation (LPS or IL4), CD206 (M2 anti-
inflammatory ATM marker) was unchanged compared to monocytes without adipocytes (RAW; 
Data not shown). When mRNA for IL-6 was measured in monocytes co-cultured with 
adipocytes from CTR or FRD 6wk, it had similar expression to that in monocytes alone (Fig. 6C). 
On the contrary, adipocytes from FRD 10wk co-cultured with monocytes induced a significant 
increase in monocyte IL-6 mRNA compared to monocytes alone. IL-6 released by adipocytes 
















observed in the mRNA (Fig 6 D). Briefly, IL-6 was not detected in monocytes cultured alone. 
When monocytes were co-cultured with CTR or FRD 6wk adipocytes no differences were 
observed between them but the co-culture with FRD 10wk adipocytes produced a significant 
increase of IL-6 compared to all the other groups. IL-6 release by co-culture of CTR 10wk was 
similar to CTR/FRD 6wk.  Thus, chronic or longer period of fructose consumption induced a 
higher proinflammatory environment of AT. 
After the co-culture, when monocytes were stimulated with IL4, we analyzed CD206 mRNA 
expression (Fig. 6E). Surprisingly neither CTR nor FRD adipocytes from 6wk or 10wk groups 
maintained M2 ATM phenotype. Even though all the groups stimulated with IL4 were 
significantly lower than the monocytes stimulated without adipocytes co-cultured, we 
observed that FRD adipocytes markedly reduced the expression of CD206 when compared to 
CTR counterparts.   
Finally, when monocytes were stimulated with LPS after co-culture with 6wk CTR or FRD 
adipocytes, we observed that monocytes had IL-6 mRNA expression similar to that of LPS 
monocytes without adipocytes (Fig. 6F). Surprisingly, when monocytes were co-cultured with 
FRD 10wk adipocytes and stimulated with LPS, it resulted in higher expression of IL-6, though it 
was not so for CTR 10wk adipocytes co-culture. The latter expression was similar to that of 
RAW LPS group. The increased expression of IL-6 in LPS stimulated monocytes co-cultured with 
FRD 10wk adipocytes was significantly different than that of the other groups. These results 
may indicate that FRD adipocytes favored the M1 ATM phenotype and prevented M2 ATM in 
EAT principally after 10wk of fructose consumption. 
 
Discussion 
Obesity is usually accompanied with AT expansion, particularly visceral, which has been 
associated with the onset of metabolic disorders [12,34]. The present study shows that high 
fructose intake in mice induces the metabolic and inflammatory altered profile characteristic 
of obesity. When we compared the different FRD periods, the longest fructose intake period 
induced the highest detrimental metabolic effects. FRD-induced obesity is associated to the 
hypertrophic expansion of AT, characterized by the altered secretion pattern of adipokines 
that in turn contribute to the development of metabolic disorders and inflammation mediated 
by macrophages. In this sense, we found low adiponectin mRNA levels after 10 weeks, which 
may favor the development of insulin resistance and promotion of inflammatory macrophages 
















[35,36]. Moreover, the higher increase of adipocyte size (hypertrophy) found in FRD 10wk may 
be related with the increase in leptin (plasma and release in vitro) and IL-6 secretion 
(spontaneously and LPS-induced) by adipocytes [37–41]. This leptin increase observed in obese 
FRD mice may favor the release of pro-inflammatory cytokines by macrophages and 
adipocytes, also favoring the development of insulin resistance (impaired insulin action on 
adipocytes) and may at the same time inhibit the adipogenic process that contributes 
adipocyte hypertrophy [42–44]. On the other hand, high leptin may also affect lipid deposition 
in the liver [45]. As we observed for the longest FRD period, the liver functionality was affected 
by the increase of liver Tg, hepatic ALT transaminase, and histological foci of lipid droplets. 
Although the deleterious effects of fructose diet are milder when compared to high fat diet, 
we and many other authors observed that obesity by chronic fructose intake induced 
metabolic disorders that got worse when time of consumption was extended [12,13,31,46].    
In agreement with other reports, we also found an increase in inflammatory markers (IL-6, IL-
1β and TNFα) and a decrease in anti-inflammatory markers (CD206: M2 marker and IL-10 ) in 
EAT from FRD mice [31,47–50]. Moreover, adipocytes isolated from FRD mice showed an 
inflammatory response (higher IL-6 release) that worsened when the obese phenotype was 
more evident (FRD 10 weeks).   
ATMs are the most abundant immune cells in AT and play a key role in the physiology and 
pathophysiology of this tissue [16,19]. M2 ATMs maintain AT homeostasis secreting IL-10 that 
contributes to insulin sensitivity and inhibition of lipolytic activity [51]. Several studies have 
shown that when the AT expands, changes in ATMs number and polarization to M1 profile 
occur [14,52]. This activation has been linked to the development of the metabolic disorders 
associated with obesity and insulin resistance [53–55]. It is important to notice that studies on 
rodents have been usually conducted using high-fat diets, but there is little information about 
inflammation in obese mice induced by fructose rich diets.  
Ly6C+ monocytes may be precursors of Ly6C- monocytes and differentiate into macrophages 
according to the cellular context [56]. There is probably no clear-cut into M1-versus-M2 states, 
but rather a dynamic continuum of the M1-M2 spectrum depending on the local cytokine 
microenvironment.  To our knowledge, there are no studies that have used Ly6C expression to 
identify the different ATM populations during AT expansion induced by a hypercaloric diet. We 
only found two reports in which Ly6C marker was used to analyze macrophages in spleen and 
lung [57,58]. Interestingly, when CD11b+Ly6C+ cells were divided into Ly6Chigh and Ly6Cmiddle, 
















increased after both periods studied. It is known that Ly6Cmiddle has pro-inflammatory profile 
that could contribute to the AT hypertrophy after both periods analyzed in this work. 
Moreover, Ly6Chigh ATMs has high phagocytosis capacity and produces pro-inflammatory 
cytokines that may favor the worsening of the disease [18]. 
Then, when we identified activated ATMs expressing Ly6C or not, we observed an increase in 
the M1 ATMs in EAT from FRD mice. Surprisingly, we found that Ly6C- M1 ATMs were more 
abundant than the Ly6C+ counterpart although both were increased during FRD intake. All this 
may indicate that many ATMs suffered polarization due to the inflammatory environment and 
this was also observed in formerly obese mice by Zamarron et al. [59]. Regarding M2 ATMs, 
FRD induced a decrease in Ly6C- M2 and did not modify Ly6C+ M2, being the first ones the 
predominant population, usually defined as resident ATMs. This is consistent with the 
literature that defines tissue resident macrophages that derive from non-classical Ly6C- 
monocytes [18,19,44]. Overall, obesity by FRD increased the M1/M2 ATMs ratio, in agreement 
with what has been described for obese mice under high fat diet, though we included the Ly6C 
marker analysis in our study [33].  
As mentioned above, M1 macrophages are divided into two subsets according to the presence 
of mannose receptor: M1a (CD11c+CD206-) and M1b (CD11c+CD206+) [18–20]. In the present 
work we were able to analyze M1a and M1b ATMs and to discriminate the presence or 
absence of Ly6C in these subsets. Our results indicate that M1a ATMs were activated earlier 
and remained high at least for the periods studied; on the contrary, M1b ATMs only increased 
after the longest FRD period. Our results show that Ly6C- M1a ATMs were found in greater 
proportion than the Ly6C+ counterpart. Probably, Ly6C- M1a ATMs derived from resident ATMs 
that polarized to inflammatory phenotype or Ly6C+ monocytes that dropped the marker during 
differentiation. M1b subset only increased in FRD 10wk mice, similar to what was found for 
humans by Nakijama in 2016 (CD11c+ and CD163+)[60]. This latter population seemed to 
activate after longer periods of inflammation and might be involved in tissue remodeling; 
however, further studies should be developed to evaluate their particular function [33].   
The paracrine interaction between adipocyte and immune cells is extremely complex and plays 
a key role in AT homeostasis. In steady state adipokines secreted by adipocytes contribute to 
maintain resident type 2 immune cells. In turn, these cells will maintain insulin sensitivity, 
browning capacity, normal pattern of adipokine secretion, and adipogenesis creating a 
virtuous cycle for the organism [35,61,62]. Several studies have used adipocyte-macrophage 
















differentiated adipocytes from mice or humans, or differentiated adipocytes from cell lines. 
Our study was performed with EAT mature adipocytes from CTR or FRD mice. We 
demonstrated that FRD 10wk adipocytes per se were able to imprint monocytes toward a M1 
phenotype and even more when LPS was added, compared to CTR and FRD 6wk. These results 
are largely coincident with a recent report by Boutens et al. which shows that preincubation of 
bone marrow derived macrophages with adipose tissue explant from obese mice favors 
metabolic and proinflammatory phenotype in macrophages [65]. On the other hand, CD206 
expression, an accepted M2 marker, was not modified under basal conditions in any co-culture 
of our experiments. However, FRD 10wk adipocytes co-culture induced the lowest levels of 
CD206 after IL4 stimulation. Further studies should be performed to analyze each one 
contribution. Considering that the recruitment of peripheral monocytes is triggered during AT 
expansion, our results could indicate that hypertrophic adipocytes facilitate a pro-
inflammatory environment that favors M1 ATMs polarization at the expense of M2 ATMs.  
Overall, the fructose obesity model detailed in this work showed the worsening of the disease 
as time of the diet extends. Our model showed the low-grade chronic inflammation, hallmark 
of obesity, where M1 macrophages were found to play an important role in the disease. 
Furthermore, M1a and M1b subpopulations were characterized, and M1b increased only after 
the longest period of FRD. It will be important to determine the role of the latter population, 
which may worsen the disease being a possible therapeutic blank. The Ly6C marker allowed to 
better characterize the macrophages population and this may encourage other groups to use 
it. Finally, hypertrophic adipocytes produce an inflammatory environment that imprint 
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Table 1. Primers used for real time PCR analysis. 





































Figure 1. Mean of caloric intake, body weight and metabolic parameters. A) Caloric intake and 
(B) body weight. C) GTT was performed four days before to the end of the protocols. Glucose 
concentration was measured at 0, 30, 60 and 120 minutes after glucose challenge. Area under 
the curve measured using the graph pad prism 6.0. D) Glucose E) Triglycerides and F) Leptin 
plasma concentrations were assessed (*P ˂0.05, ** P ˂0.01, *** P˂0.001 and ****P ˂0.0001 
vs. CTR; +P˂0.05 and +++P˂0.001 vs. FRD 6wk). Values are mean ± SD (n=10 mice per group). 
Figure 2. AT expansion, function and metabolic gene expression along FRD period. A) EAT B) 
IAT and C) RPAT mass were weighted. D) representative EAT histological samples stained with 
hematoxylin-eosin and E) EAT adipocyte size. F) Leptin secretion of adipocytes incubated with 
basal medium. G) EAT mRNA expression of adiponectin (Adipo) and leptin (Lep). *P ˂0.05, ** P 
˂0.01, ***P ˂0.001, ****P ˂0.001  vs. CTR; +P ˂0.05, ++P ˂0.01 vs. FRD 6wk. Values are mean ± 
SD (n=6-8 mice per group). 
Figure 3. Liver histology and metabolic parameters along FRD period. A) ALT and AST activity 
measurement B) Liver triglycerides content C) representative liver histological samples stained 
with hematoxylin-eosin and  D) with higher magnification of the selected area. *P ˂0.05; ** 
P˂0.01 vs. CTR; +++ P ˂0.001 vs. FRD 6wk. Values are mean ± SD (n=8-10 mice per group). 
Figure 4. Inflammatory markers (mRNA). A) Gene expression of pro-inflammatory cytokines 
IL6, TNFα and IL1β and  B) anti-inflammatory markers, CD206 and IL10, from EAT of CTR and 
FRD after 6 and 10wk. *P ˂0.05, **P˂0.01 vs. CTR. Values are mean ± SD (n= 6 mice per group). 
Figure 5. Flow cytometry analysis of myeloid population in AT along FRD period. A) 
Representative density plots of ly6C study using SVF cells from EAT of CTR10wk and FRD10wk. 
B) Quantitative Ly6C expression analyzed by flow cytometry (% to CD11b+ cells)  C) 
representative plots of M1 ATMs and subtypes (M1a and M1b) and M2 ATMs in SVF cells from 
















D) M1 ATMs; E) M1a and M1b subtypes (% to CD11b+ cells) and  F) M2 ATMs (% to 
CD11b+CD206+ cells)  expression. *P ˂0.05, ** P ˂0.01, ***P ˂0.001 ****P ˂0.0001 vs. CTR; +P 
˂0.05; +++P ˂0.001  vs. FRD 6wk. Values are mean ± SD (n=6-8 mice per group).  
Figure 6. Adipocytes IL6 release and co-culture with monocytes cell line (RAW264.7) A) IL6 
secretion of adipocytes culture incubated with basal medium or LPS in the different groups. B) 
in vitro experimental set-up of RAW264.7 co-culture with adipocytes ON from CTR or FRD mice 
followed with 6h monocytes stimulation with LPS (100ng/ml) or IL4 (10ng/ml). C) IL6 mRNA 
expression of monocytes from co-culture or alone. D) IL6 secretion from co-culture or 
monocytes alone. E,F). CD206 or IL6 mRNA expression assessed in RAW2064.7 after LPS 
(100ng/ml) or IL4 (10ng/ml) stimulation, respectively. mRNA samples are referred to 
monocytes without stimulation.  *P ˂0.05, **P ˂0.01, ***P˂0.001, ****P ˂0.0001 vs. CTR, 
#P˂0.05,##P˂0.01 vs. RAW264.7; +P˂0.05, ++P ˂0.01, +++ P˂0.001 and ++++P ˂0.0001 vs. FRD 
6wk, Δ P˂0.05 vs. all the groups. Values are mean ± SD (n=6 mice per group). 
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